Track CBIO and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CBIO - Crescent Biopharma, Inc. (CBIO) has a earnings per share of -$0.70, up 96.2% over the past year.
Latest EPS (Actual)
-$0.70
Beat Rate
25.0%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Apr 2026 | -$0.79 | -$0.70 | Beat | +11.02% |
| Feb 2026 | -$2.22 | -$4.01 | Miss | -80.63% |
| Nov 2025 | -$1.38 | -$1.37 | Meet | +0.72% |
| Jul 2025 | -$3.68 | -$3.72 | Meet | -1.09% |
| Jun 2025 | -$3.64 | -$18.39 | Miss | -405.22% |
| Feb 2025 | -$0.09 | -$0.08 | Beat | +11.11% |
| Nov 2024 | -$0.11 | -$15.24 | Miss | -13750.27% |
| Aug 2024 | -$0.16 | -$0.16 | Meet | +3.13% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.